结果：最大体重和糖化血红蛋白减少发生在头3个月。
RESULTS: the greatest reduction in weight and A1C occurred within the first 3 months.
葡萄糖变异是否会影响1型和2型糖尿病患者平均血糖和糖化血红蛋白水平间的关系？
Does Glucose Variability Influence the Relationship Between Mean Plasma Glucose and HbA1c Levels in Type 1 and Type 2 Diabetic Patients?
采用医学应对问卷测定患者的应对方式，同时，测量体重、血压、血糖和糖化血红蛋白等指标。
Medical coping Modes Questionnaire was used for measuring coping style of patients, and weight, blood pressure, blood glucose and hemoglobin of glycosylation were measured at the same time.
因为如果糖化血红蛋白水平下降10%，眼部和肾脏的并发症发生率就会随之减少，为此这一试验结果使人倍受鼓舞。
Since even a 10% decline in HbA1c level is associated with a reduction in complications such as eye and kidney problems, this is an impressive result.
另外，相对于安慰机组，利妥昔单抗组的糖化血红蛋白和胰岛素必须量都明显较低。
The rituximab group also had significantly lower levels of glycated hemoglobin and required less insulin.
糖化血红蛋白浓度与心血管和所有原因的死亡有着单一的联系。
Glycated haemoglobin concentration has a monotonic relationship with cardiovascular and all-cause mortality.
本文对糖化血红蛋白检测的临床意义及常用方法和仪器作了简单介绍。
This paper briefly introduced the clinical significance, commonly used methods and instruments in hemoglobin Alc measurement.
糖尿病血液透析患者糖化白蛋白是比糖化血红蛋白更好的升血糖指数：贫血和注射促红素对其的影响。
Glycated Albumin is a Better Glycemic Indicator than Glycated Hemoglobin Values in Hemodialysis Patients with Diabetes: Effect of Anemia and Erythropoietin Injection.
糖化血红蛋白水平之间开始了类似的武器和治疗16周，平均每场类似的7.2%至7.4%的为在糖化血红蛋白变化的主要终点无显着差异。
Hemoglobin A1c levels started out similar between treatment arms and averaged a similar 7.2% to 7.4% at 16 weeks with no significant differences for the primary endpoint of change in hemoglobin A1c.
未使用信息系统的对照组，糖化血红蛋白和血糖都没有变化。
Control patients who did not use the messaging system saw no change in their hemoglobin A1C or blood sugar levels.
影响的因素主要有年龄、病程、文化程度、知晓程度、糖化血红蛋白和总胆固醇等。
The influential factors of QOL mainly include age, course of disease, record of formal schooling, recognition, HbAl, total cholesterol and so on.
起病年龄、体重指数、空腹血糖、糖化血红蛋白、高密度脂蛋白和糖尿病肾病等指标是线粒体基因突变的相关因素（P<0.05）。
Onset age, body mass index, fasting blood glucose, HbA1C, high density lipoprotein-cholesterol and diabetic nephropathy could be related to occurrence of mtDNA mutations (P<0.05).
方法将DM大鼠随机分为西洛他唑治疗组和DM组，用药8周后检测两组血糖、体质量、糖化血红蛋白、心脏重量指数，观察其心肌细胞超微结构变化。
DM rats were randomly divided into cilostazol group and DM group. 8 weeks after treatment, blood glucose, body weight, HbA1c, cardiac weight index and ultrastructure of myocardiocyt were observed.
侵略性，早期治疗2型糖尿病，其目标是实现最高糖化血红蛋白的8 %，一个理想的不到7 %，既卫生加强和成本效益。
Aggressive, early treatment of type 2 diabetes, with the goal of achieving a maximum HbA1c of 8% and an ideal of less than 7%, is both health-enhancing and cost-effective.
目的糖化血红蛋白指导下的术前血糖控制对于白内障超声乳化手术的安全性和有效性的观察。
Objective To investigate the safety and effect of blood glucose control directed by HbAlc before PHACO and IOL implantation on cataract patients with DM.
基线糖化血红蛋白水平百分之5.48和5.42百分之充分剂量和中剂量组。
Baseline HbA1c levels were 5.48 percent and 5.42 percent for the full-dose and mid-dose groups.
糖尿病维持组中血糖、胆固醇、甘油三酯、糖化血红蛋白明显高于糖尿病治疗组和正常对照组；
Compared with the other two groups, the levels of blood glucose, cholesterol, trigalloyl glycerol, HbA1c in DM group increased significantly.
糖尿病维持组中血糖、胆固醇、甘油三酯、糖化血红蛋白明显高于糖尿病治疗组和正常对照组；
Compared with the other two groups, the levels of blood glucose, cholesterol, trigalloyl glycerol, HbA1c in DM group increased significantly.
应用推荐